Evidence map›Paper›PMID 29276411›Full record

ArticleClinical epidemiology2017

The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs.

Clementine Nordon, Constance Battin, Helene Verdoux, Josef Maria Haro, Mark Belger, Lucien Abenhaim, Tjeerd Pieter van Staa

Abstract read
In one paragraph

Article in Clinical epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clementine NordonEpidemiological Research, Analytica LASER, Paris.
Constance BattinEpidemiological Research, Analytica LASER, Paris.
Helene VerdouxPopulation Health Research Center, Team Pharmaco-Epidemiology, UMR 1219, Bordeaux-2 University, INSERM, Bordeaux, France.
Josef Maria HaroParc Sanitari Sant Joan de Deu, CIBERSAM, University of Barcelona, Barcelona, Spain.
Mark BelgerEli Lilly and Company Limited, Erl Wood Manor, Windlesham.
Lucien AbenhaimEpidemiological Research, Analytica LASER, Paris.
Tjeerd Pieter van StaaFarr Institute, University of Manchester, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA case study was conducted, exploring methods to identify drugs effects modifiers, at a health care center level. PATIENTS AND

methodsData were drawn from the Schizophrenia Outpatient Health Outcome cohort, including hierarchical information on 6641 patients, recruited from 899 health care centers from across ten European countries. Center-level characteristics included the following: psychiatrist's gender, age, length of practice experience, practice setting and type, countries' Healthcare System Efficiency score, and psychiatrist density in the country. Mixed multivariable linear regression models were used: 1) to estimate antipsychotic drugs' effectiveness (defined as the association between patients' outcome at 3 months - dependent variable, continuous - and antipsychotic drug initiation at baseline - drug A vs other antipsychotic drug); 2) to estimate the similarity between clustered data (using the intra-cluster correlation coefficient); and 3) to explore antipsychotic drug effects modification by center-related characteristics (using the addition of an interaction term).

resultsAbout 23% of the variance found for patients' outcome was explained by unmeasured confounding at a center level. Psychiatrists' practice experience was found to be associated with patient outcomes (

conclusionMixed models may be useful to explore how center-related characteristics modify drugs' effect estimates, but require numerous assumptions.

Indexed as

effectivenesseffect modificationhealth care systemhierarchical modelschizophrenia

Identifiers

PMID29276411
PMCPMC5733906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.